Hey Cathy, I found this about Type 2 diabetes, thought it might be of some interest to you?
TORONTO (CP) - A drug used to treat Type 2 diabetes appears to prevent onset of the disease in some people who are at high risk of developing it, authors of a large international study reported Friday.
The Canadian-led trial found people who took the drug rosiglitazone (sold as Avandia) and who were given advice about lowering their risk through diet and exercise were substantially less likely to develop diabetes in the three years of followup than people who received lifestyle advice and took a placebo.
|